Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MOOG INC. M&A Activity 2008

Dec 31, 2008

30876_rns_2008-12-31_7e4a1cb9-51c1-41df-aeb8-83c06dc2c494.zip

M&A Activity

Open in viewer

Opens in your device viewer

8-K 1 v135979_8k.htm

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 30, 2008

MOOG INC.

(Exact name of registrant as specified in its charter)

| New
York | 1-5129 | 16-0757636 |
| --- | --- | --- |
| (State
or Other Jurisdiction | (Commission | (I.R.S.
Employer |
| of
Incorporation) | File
Number) | Identification
No.) |
| East
Aurora, New York | | 14052-0018 |
| (Address
of principal executive offices) | | (Zip
Code) |

Registrant’s Telephone Number, Including Area Code: (716) 652-2000

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

r Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

r Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

r Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On December 30, 2008 Moog Inc. (the “Company”) issued a press release announcing that the Company has acquired 100% of the stock of AITECS Medical UAB, a Lithuanian-based manufacturer of syringe-style infusion therapy pumps, for €15 million ($21 million), paid in cash. Founded in 1993, AITECS has a product portfolio that includes pumps for general hospital use, operating rooms and patient controlled analgesia.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press release dated December 30, 2008

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| MOOG
INC. — By: | /s/ Jennifer
Walter |
| --- | --- |
| Name: | Jennifer
Walter |
| | Controller |

EXHIBIT INDEX

Exhibit Description
99.1 Press
release dated December 30,
2008